When kidneys are no longer a friend: An “out of the box” management for an unexpected evolution of an uncommon disease  by Silva, Sandra et al.
n e f r o l o g i a 2 0 1 6;3  6
When  kidneys  are no  longer  a fr
management for  an  unexpected
disease
Cuando  los  rin˜ones  dejan  de  ser  un  a
caja”  de  una  evolución  imprevista  de
poco  común
Dear Editor,
AA amyloidosis (AAA) is one of most severe complications
of chronic inﬂammatory and infectious diseases and may
induce nephrotic syndrome.1 Its association with Crohn’s
disease has been regularly reported, but amyloidosis com-
plicating ulcerative colitis (UC) has been described only
exceptionally.2
We  report a case of a 58-year-old woman who was admit-
ted with anasarca and nephrotic syndrome (NS). Relevant
medical history included UC, gangrenous pyoderma and a
tuberculous empyema. In 2002, a NS was identiﬁed and a
renal biopsy displayed the diagnosis of AAA. In addition to
treatment with 5-aminosalicylic-acid, a trial of colchicine
was implemented but had to be stopped due to diarr-
hea. Renal function (RF) was sustainably preserved and the
proteinuria spontaneously remitted. Throughout time she
had long-lasting, moderate gastrointestinal symptoms with
evidence of mild endoscopic inﬂammation. In 2015 she deve-
loped once more  disabling proteinuria with normal RF and
a diagnostic workup corroborated the clinical impression
of recurrence of her amyloidosis (Table 1). An endoscopic
review exhibited mild disease and, in addition to messala-
zine and prednisone, she was started on azathioprine, which
had to be suspended due to pancreatitis. Therapy with an
angiotensin-converting enzyme inhibitor was initiated but
not tolerated; albumin-plus-furosemide infusion led merely
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i et al. reported that in 1/3 of the patients, dialysis was noto temporary improvement. A decision to deteriorate RF to
ecrease proteinuria was attempted: indomethacin led to
cute renal dysfunction but didn’t signiﬁcantly improved pro-
einuria. Hemodialysis was started but had to be interrupted
ue to hemodynamic instability. After a multidiscipli-
ary consultation, she underwent a bilateral nephrectomy.
ost-operatively, serum albumin and postural symptoms
radually improved with subsequent better hemodialysis
olerance. Histology revealed extensive amyloid deposits
Fig. 1) and immunohistochemical staining was positive for
A amyloid. Nutritional and functional status gradually
mproved.(5):556–581 563
iend:  An “out  of the box”
 evolution  of an  uncommon
migo:  Una  gestión  “fuera  de  la
 una  enfermedad
AAA in the setting of UC is a rarity and typically,
severe gastrointestinal illness precedes the development of
amyloidosis,3 however this was not the case in our patient,
who had a long standing, though mild disease. We speculate
that the ongoing activity and the prolonged duration may have
had a role; nevertheless, an additional contribution from the
tuberculosis cannot be ruled out.
Another peculiar aspect is the spontaneous remission of
the patient’s NS. Improvement of amyloidosis manifestations
is extensively documented in the context of remission of the
underlying disease, but spontaneous regression is extremely
unlikely.4
Patients with large proteinuria due to AAA can experience
a life-threatening cachexic state with massive edema, respi-
ratory distress and infectious complications, along with a
poor functional status and a reduced quality-of-life. Up  to
the present, AAA has no speciﬁc treatment and despite the
development of novel therapies (eprodisate)5 targeting the for-
mation/stability of ﬁbrils, the current available approach is to
treat the underlying condition and thereby reduce the amyloid
production. Nevertheless, this goal is not always achieved and
the management of proteinuria can be challenging, resorting,
in intractable cases like ours, to renal ablation. Medical abla-
tion, with non-steroidal anti-inﬂammatory drugs6 has been
attempted; bilateral renal artery embolization is an alterna-
tive, although frequently complicated by a ‘post-infarction
syndrome’.7 Recently, bilateral ureteral ligation8 has been des-
cribed, but the experience is limited and can induce persistent
loin pain and ascending infections. Surgical nephrectomy is
another option: although laparoscopic surgery is a less inva-
sive procedure than an open nephrectomy, it precludes the
chance for peritoneal dialysis and, consequently, we elected a
bilateral nephrectomy by lombotomy.
The histological examination of the kidneys revealed
extensive presence of AA amyloid deposits comprising the
glomeruli, the blood vessels and the interstitium, an infre-
quent ﬁnding in the review by Hopfer et al.,9 who  reported
interstitium involvement in only 5.9%.
AAA has a major impact in patient’s quality of life: Esteve
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Table 1 – Laboratory tests results.
Result Reference range
Hemoglobin (g/dL) 9.7 12–16
Leukocytes (103/L) 9.3  4–11
Platelets (103/L) 183  150–400
C-reactive protein (mg/L/sedimentation rate 1st h) 24/127 <5/0–30
Total protein/albumin (g/dL) 4.4/1.2 6.4–8.3/3.5–5.0
AST/ALT/LDH (U/L)a 11/18/205 5–34/<55/110–220
Fasting glucose/total bilirubin (mg/dL) 83/0.7 60–110/0.2–1.2
Total/LDL/HDL cholesterol (mg/dL) 270/169/40 <200/<100/≥60
Urea/creatinine (mg/dL) 52/0.7 21–43/0.6–1.1
Urinalysis/24 hours protein (mg/day) 4+ proteinuria/19 538 0+/<300
Serum immunoelectrophoresis/serum kappa-lambda ratio Absence of monoclonal
gammopathy/normal
Urinary electrophoresis/urinary immunoelectrophoresis Albumin = 46% and gamma
globulin = 14%/no band
suggestive of monoclonality
Tests for hepatitis B and C, HIVb, and syphilis Negative
ANA, anti-dsDNA and ANCAc antibodies; C3 and C4
complement levels
Normal
Serum amyloide A (mg/L) 79.4 <7
a AST: aspartate transaminase, ALT: alanine transaminase, LDH: lactate dehydrogenase.
b HIV: human immunodeﬁciency virus.
c ANA: antinuclear antibodies, anti-dsDNA: anti-double stranded DNA antibodies, ANCA: antineutrophil cytoplasmic antibodies.
Fig. 1Histological examination of the kidneys. (A) Glomerular nodular deposits of amyloid stained with Congo red. (B)
Amyloid showing typical apple-green birefringence under polarized light.
performed due to their poor clinical condition and disturbing
quality of life. Bilateral nephrectomy in our patient, led to
an improvement in hemodynamic stability allowing hemo-
dialysis to be accomplished. Additionally, her functional and
nutritional status enhanced gradually.
Radical bilateral nephrectomy may be considered in
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BK  virus  nephropathy  in  a renal  transplant  patient:  Potential
role of  electron  microscopy  in diagnosis
Nefropatía  por  virus  BK  en  un  paciente  con  trasplante  renal:  Papel
potencial  de  la  microscopía  electrónica  en  el  diagnóstico
Dear Editor,
BK polyomavirus (BKV) causes latent, asymptomatic infection
in immunocompetent individuals. In the setting of immu-
nosuppression BKV can reactivate and lead to BK virus
nephropathy (BKVN) in renal transplant recipients.1 BKVN is
one of the main causes of allograft failure in renal transplant
patients. Acute rejection and different viral infections should
be considered in differential diagnosis of renal allograft dys-
function. Electron microscopy (EM) could help to distinguish
BKV from other viral factors in allograft tissue.2 Herein, we
described inclusions due to BKV seen by EM in a renal trans-
plant biopsy and we discussed potential role of EM in diagnosis
of BKVN.
A 49 years old woman had renal transplantation from
non-relative donor 2 years ago. Although she was asymp-
tomatic, her serum creatinine level was increased gradually
during last 3–4 months (from 1.2 mg/dl to 1.7 mg/dl). Her
primary renal disease was unknown. She had been under
the treatment of tacrolimus 2 + 1 mg,  prednisolone 5 mg,
mycophenolate sodium 3 × 360 mg.  Physical examination was
normal. Serum creatinine was 1.82 mg/dl, urine microscopy
was normal. 154 mg/day proteinuria was obtained. ANA was
positive, though ENA was negative. Anti CMV IgM was nega-
tive, whereas serum BK/JC PCR was positive. Serum tacrolimus
level was 9.5 ng/ml. Transplant renal doppler ultrasonography
revealed normal ﬁndings. Renal biopsy was performed. Intra-
nuclear inclusions, cytoplasmic and nuclear enlargement in
tubular epithelial cells and tubular necrosis were seen on
light microscopy. These biopsy ﬁndings might suggest viral
infection of the renal allograft. Immunohistochemical analy-
sis of the renal biopsy for CMV was negative, but study with
SV40 antigen could not be performed as it was not availa-
ble in our center. Intranuclear spherical viral particles were
seen in some tubular epithelial cells on EM (Fig. 1). Viral par-
ticles were in paracrystalline structure and about 30 nm in
diameter. They were differentiated from inclusions of adeno-
virus with 80–100 nm in diameter (Fig. 2). Finally, BKVN was
diagnosed.
BKVN is one of the well-known reasons of morbidity in
renal transplant patients. It occurs with a prevalence of 1–10%
in renal transplant patients and graft loss is up to 80%.3,4 BKVN
occurs mostly during the ﬁrst year after transplantation and it
is characterized only by deterioration of renal functions, usua-
lly without any symptoms.1 Early diagnosis is important to
prevent allograft dysfunction in kidney transplant patients.
Our patient was also declared no symptoms, but only a gra-
dual increase in serum creatinine was observed in the second
year of follow up.
